Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach §130c Abs. 1 SGB V / § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Cladribin (ATC: L04AA40).

Conclusion of a non-exclusive discount contract pursuant to §130c para. 1 SGB V / § 130a para. 8 SGB V for medicinal products with the active substance Cladribin (ATC: L04AA40) within the period from 01.03.2026 to 29.02.2028 with the possibility of concluding the contract at any time during the contract period (open-house model).